You just read:

Spark Therapeutics Appoints Industry Leader Dr. Elliott Sigal, Former Executive Vice President and Chief Scientific Officer of Bristol-Myers Squibb, to Board of Directors

News provided by

Spark Therapeutics

Feb 11, 2014, 08:15 ET